Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A)
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>KCE</strong> <strong>reports</strong> vol.45 Screen<strong>in</strong>g for Colorectal Cancer: Appendices 181<br />
Nr. Title Issued by Year Familial Adenomatous Polyposis<br />
(FAP) & related<br />
7 Surveillance and<br />
management of groups at<br />
<strong>in</strong>creased risk of<br />
colorectal cancer 27.<br />
New Zealand<br />
Guidel<strong>in</strong>es Group<br />
(NZGG)<br />
2004 1. Offer referral to a genetic<br />
service for consideration of<br />
genetic test<strong>in</strong>g <strong>with</strong><strong>in</strong> the context<br />
of appropriate counsel<strong>in</strong>g to:<br />
Individuals <strong>with</strong> a cl<strong>in</strong>ical<br />
diagnosis of FAP<br />
All at-risk family members if a<br />
family-specific genetic mutation<br />
has been identified at the age<br />
when sigmoidoscopic surveillance<br />
would normally beg<strong>in</strong><br />
2. Sigmoidoscopy 1- to 2-yearly<br />
from the age of 12 to 15 y is<br />
recommended for asymptomatic<br />
<strong>in</strong>dividuals <strong>with</strong> an identified<br />
disease-caus<strong>in</strong>g FAP mutation and<br />
for all at-risk members of families<br />
<strong>with</strong> FAP if genetic test<strong>in</strong>g is not<br />
available or is non<strong>in</strong>formative.<br />
3. Increase the <strong>in</strong>terval for<br />
sigmoidoscopic surveillance to 3yearly<br />
at 35 y if previous<br />
exam<strong>in</strong>ations have been normal.<br />
Consider cessation at 55 y.<br />
4. If attenuated FAP is suspected,<br />
colonoscopy is advised. Depend<strong>in</strong>g<br />
on the family history this may<br />
beg<strong>in</strong> as late as 18 y and cont<strong>in</strong>ue<br />
beyond 55 y.<br />
5. Gastroduodenoscopy to detect<br />
duodenal adenomas at 1- to 3yearly<br />
<strong>in</strong>tervals from 30 to 35 y is<br />
commonly advised, as most<br />
advanced duodenal adenomas<br />
develop after the age of 40 years.<br />
The Spigelman Criteria may be<br />
used to guide surveillance <strong>in</strong>terval.<br />
Recommendations all grade 3<br />
except for 5. (grade 5)<br />
Hereditary Non-Polyposis<br />
Colon Cancer (HNPCC)<br />
1. Offer referral to a genetic<br />
service for consideration of<br />
genetic test<strong>in</strong>g, <strong>with</strong><strong>in</strong> the<br />
context of appropriate<br />
counsell<strong>in</strong>g, to all at-risk<br />
members of families <strong>with</strong><br />
HNPCC, at the age when<br />
colonoscopic surveillance<br />
would normally beg<strong>in</strong>.<br />
2. For bowel surveillance<br />
colonoscopy is<br />
recommended 2-yearly from<br />
the age of 25 years (or from<br />
an age 5 years before the<br />
earliest age at which CRC<br />
was diagnosed <strong>in</strong> the family,<br />
whichever comes first).<br />
Consider annual<br />
colonoscopy <strong>in</strong> known<br />
mutation carriers.<br />
3. Endometrial cancer is the<br />
most common extracolonic<br />
malignancy. Surveillance <strong>with</strong><br />
annual transvag<strong>in</strong>al<br />
ultrasound (+/- endometrial<br />
aspiration biopsy) is usually<br />
advised for known mutation<br />
carriers and at-risk members<br />
of families <strong>with</strong> HNPCC as<br />
determ<strong>in</strong>ed by the<br />
Amsterdam Criteria if there<br />
is a family history of uter<strong>in</strong>e<br />
cancer and/or genetic test<strong>in</strong>g<br />
is non<strong>in</strong>formative<br />
The efficacy of these<br />
surveillance tools rema<strong>in</strong>s<br />
uncerta<strong>in</strong> <strong>in</strong> premenopausal<br />
younger women.<br />
Recommendations all grade<br />
5, except for 2. (grade 3)<br />
Personal history of CRC<br />
resection<br />
1. Follow-up after resection<br />
of CRC <strong>with</strong> curative <strong>in</strong>tent<br />
is recommended as it allows<br />
practitioners to monitor<br />
treatment outcome and is<br />
consistent <strong>with</strong> the<br />
preference of <strong>in</strong>dividuals<br />
<strong>with</strong> CRC.<br />
2. All such <strong>in</strong>dividuals should<br />
have specialist follow-up<br />
over the time period <strong>in</strong><br />
which the majority of<br />
recurrences (local or<br />
metastatic) are most likely<br />
to occur (3-5 years).<br />
Follow-up should be<br />
appropriate to the cl<strong>in</strong>ical<br />
context. In decid<strong>in</strong>g on<br />
<strong>in</strong>tensity and duration of<br />
follow-up, age and comorbid<br />
conditions should be<br />
considered.<br />
Follow-up should occur <strong>in</strong><br />
conjunction <strong>with</strong>, and<br />
subsequently be cont<strong>in</strong>ued<br />
by, the <strong>in</strong>dividuals general<br />
practitioner.<br />
3. Individuals free of<br />
recurrent CRC for 3 to 5<br />
years should be entered <strong>in</strong>to<br />
a colonoscopy surveillance<br />
program.<br />
Colonoscopy should be<br />
performed at 3- to 5-yearly<br />
<strong>in</strong>tervals.<br />
4. All <strong>in</strong>dividuals <strong>with</strong> CRC<br />
should be <strong>in</strong>formed of the<br />
uncerta<strong>in</strong> efficacy of followup<br />
<strong>with</strong> regard to survival<br />
benefit.<br />
All recommendations grade<br />
5<br />
Personal history of<br />
colonpolyps<br />
1. Adenoma size > 10<br />
mm: colonoscopy<br />
after 3 years - if<br />
negative subsequent<br />
colonoscopy after 3-<br />
5 y<br />
2. > 3 adenomas:<br />
Colonoscopy after 3<br />
years - if negative<br />
subsequent<br />
colonoscopy after 3-<br />
5 y<br />
3. Villous lesions<br />
and/or severe<br />
dysplasia:<br />
Colonoscopy after 3<br />
years - if negative<br />
subsequent<br />
colonoscopy after 3-<br />
5 y<br />
4. Adenomas <strong>with</strong> no<br />
high-risk features and<br />
significant family<br />
history of CRC:<br />
colonoscopy after 3 y<br />
5. Adenomas <strong>with</strong> no<br />
high-risk features and<br />
no family history of<br />
CRC: colonoscopy<br />
after 5-6 y; consider<br />
discont<strong>in</strong>u<strong>in</strong>g<br />
surveillance if<br />
subsequent<br />
surveillance<br />
colonoscopy normal.<br />
All recommendations<br />
grade 3<br />
Inflammatory bowel disease<br />
(IBD)<br />
1. After 8 to 10 years, <strong>in</strong>dividuals<br />
<strong>with</strong> ulcerative colitis (UC)<br />
should undergo colonoscopy<br />
<strong>with</strong> serial biopsies (as detailed<br />
below) to def<strong>in</strong>e disease extent,<br />
both macroscopic and<br />
microscopic. All those <strong>with</strong><br />
significant disease extend<strong>in</strong>g<br />
proximal to the sigmoid colon<br />
should be enrolled <strong>in</strong> a<br />
surveillance program.<br />
2. Colonoscopy is recommended<br />
2-yearly for <strong>in</strong>dividuals <strong>with</strong> UC<br />
after 10 years' disease duration.<br />
At colonoscopy, 2 to 3 biopsies<br />
should be taken from each of 10<br />
sites (caecum, proximal and<br />
distal ascend<strong>in</strong>g colon, proximal<br />
and distal transverse colon,<br />
proximal and distal descend<strong>in</strong>g<br />
colon, proximal and distal<br />
sigmoid colon, and rectum).<br />
Additional biopsies should be<br />
taken from any mass lesions, but<br />
not from pseudopolyps.<br />
3. If high-grade dysplasia (HGD)<br />
is present on biopsy (and<br />
confirmed on histological<br />
review), the <strong>in</strong>dividual should be<br />
referred for colectomy. If lowgrade<br />
dysplasia (LGD) is found <strong>in</strong><br />
the absence of significant<br />
<strong>in</strong>flammation, shorten the<br />
surveillance <strong>in</strong>terval to 1 year<br />
and refer for surgery<br />
4. All <strong>in</strong>dividuals <strong>with</strong> extensive<br />
colorectal Crohn s disease<br />
should undergo surveillance<br />
procedures as detailed for<br />
<strong>in</strong>dividuals <strong>with</strong> extensive UC.<br />
Recommendations grade 3, for<br />
Crohn s disease grade 4<br />
Miscellaneous<br />
1. Individuals <strong>with</strong><br />
hamartomatous polyps<br />
of the large or small<br />
bowel, or those <strong>with</strong> a<br />
first-degree relative<br />
known to have multiple<br />
polyps alone or<br />
associated <strong>with</strong> CRC,<br />
should be referred to<br />
the appropriate bowel<br />
and genetic specialists.<br />
2. Individuals identified<br />
to have hyperplastic<br />
polyps beyond the<br />
rectosigmoid junction<br />
<strong>with</strong> risk features<br />
should be referred to<br />
the appropriate bowel<br />
and genetic specialists.<br />
Risk features <strong>in</strong>clude:<br />
Unusual numbers (><br />
20)<br />
Unusual size (> 10<br />
mm)<br />
Location <strong>in</strong> the<br />
proximal colon<br />
Presence of highgrade<br />
dysplasia<br />
Co<strong>in</strong>cidental<br />
adenomas<br />
A first-degree relative<br />
<strong>with</strong> high-risk<br />
hyperplastic polyps<br />
A first-degree relative<br />
<strong>with</strong> CRC<br />
Recommendations all<br />
grade 5